Intelligent Bio Solutions Inc/$INBS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Ticker
$INBS
Sector
Primary listing
Employees
54
Headquarters
Website
INBS Metrics
BasicAdvanced
$6m
-
-$11.36
4.24
-
Price and volume
Market cap
$6m
Beta
4.24
52-week high
$24.90
52-week low
$2.27
Average daily volume
160k
Financial strength
Current ratio
2.114
Quick ratio
1.802
Long term debt to equity
16.68
Total debt to equity
21.122
Interest coverage (TTM)
-236.73%
Profitability
EBITDA (TTM)
-10.233
Gross margin (TTM)
47.25%
Net profit margin (TTM)
-296.77%
Operating margin (TTM)
-286.13%
Revenue per employee (TTM)
$70,000
Management effectiveness
Return on assets (TTM)
-57.25%
Return on equity (TTM)
-170.19%
Valuation
Price to revenue (TTM)
0.651
Price to book
0.56
Price to tangible book (TTM)
0.84
Price to free cash flow (TTM)
-0.226
Free cash flow yield (TTM)
-443.44%
Free cash flow per share (TTM)
-11.041
Growth
Revenue change (TTM)
33.26%
Earnings per share change (TTM)
-52.61%
3-year revenue growth (CAGR)
68.79%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs